These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 7407790)

  • 21. Designing and analyzing clinical trials which allow institutions to randomize patients to a subset of the treatments under study.
    Schoenfeld DA; Gelber RD
    Biometrics; 1979 Dec; 35(4):825-9. PubMed ID: 526527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restricted randomization designs in clinical trials.
    Simon R
    Biometrics; 1979 Jun; 35(2):503-12. PubMed ID: 486683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical trial designs for predictive marker validation in cancer treatment trials.
    Sargent DJ; Conley BA; Allegra C; Collette L
    J Clin Oncol; 2005 Mar; 23(9):2020-7. PubMed ID: 15774793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generalized multidimensional dynamic allocation method.
    Lebowitsch J; Ge Y; Young B; Hu F
    Stat Med; 2012 Dec; 31(28):3537-44. PubMed ID: 22736449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment allocation for nonlinear models in clinical trials: the logistic model.
    Begg CB; Kalish LA
    Biometrics; 1984 Jun; 40(2):409-20. PubMed ID: 6487725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bias in treatment assignment in controlled clinical trials.
    Chalmers TC; Celano P; Sacks HS; Smith H
    N Engl J Med; 1983 Dec; 309(22):1358-61. PubMed ID: 6633598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preserving the allocation ratio at every allocation with biased coin randomization and minimization in studies with unequal allocation.
    Kuznetsova OM; Tymofyeyev Y
    Stat Med; 2012 Apr; 31(8):701-23. PubMed ID: 22161821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ethical approach to randomization in oncology.
    Arpaillange P; Dion S
    Drugs Exp Clin Res; 1986; 12(1-3):99-103. PubMed ID: 3732058
    [No Abstract]   [Full Text] [Related]  

  • 29. Adaptive biased urn randomization in small strata when blinding is impossible.
    Schouten HJ
    Biometrics; 1995 Dec; 51(4):1529-35. PubMed ID: 8589238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomization with a posteriori constraints: description and properties.
    Gicquel S; Marion-Gallois R
    Stat Med; 2007 Nov; 26(27):5033-45. PubMed ID: 17721873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of minimization in clinical trials.
    Taves DR
    Contemp Clin Trials; 2010 Mar; 31(2):180-4. PubMed ID: 20060500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adaptive regression.
    Proschan MA; Leifer E; Liu Q
    J Biopharm Stat; 2005; 15(4):593-603. PubMed ID: 16022165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic significance of patient-reported outcomes in cancer clinical trials.
    Gotay CC; Kawamoto CT; Bottomley A; Efficace F
    J Clin Oncol; 2008 Mar; 26(8):1355-63. PubMed ID: 18227528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allocation of patients to conditions in headache clinical trials: randomization, stratification, and treatment matching.
    Lipchik GL; Nicholson RA; Penzien DB
    Headache; 2005 May; 45(5):419-28. PubMed ID: 15953258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Design and analysis of a treatment study in urological clinical research].
    Vargas Castrillón E; Terleira Fernández A
    Arch Esp Urol; 2003; 56(6):615-28. PubMed ID: 12958996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The "best balance" allocation led to optimal balance in cluster-controlled trials.
    de Hoop E; Teerenstra S; van Gaal BG; Moerbeek M; Borm GF
    J Clin Epidemiol; 2012 Feb; 65(2):132-7. PubMed ID: 21840173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical trials symposium. Highlights in development of randomized clinical trials.
    Forbes JF
    Med J Aust; 1981 Feb; 1(4):159-60. PubMed ID: 6939955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A treatment allocation procedure for sequential clinical trials.
    Begg CB; Iglewicz B
    Biometrics; 1980 Mar; 36(1):81-90. PubMed ID: 7370375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of prognostic factors in cancer clinical trials.
    Simon R
    Cancer Treat Rep; 1984 Jan; 68(1):185-92. PubMed ID: 6362863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On design considerations and randomization-based inference for community intervention trials.
    Gail MH; Mark SD; Carroll RJ; Green SB; Pee D
    Stat Med; 1996 Jun; 15(11):1069-92. PubMed ID: 8804140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.